Assenagon Asset Management S.A.
Position in FATE — Fate Therapeutics Inc
CIK 1546007
SENNINGERBERG, N4
Position in FATE
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$393,762
+$165,460 QoQ
Shares Held
145,838
-23.3% QoQ
Ownership
0.125%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 7 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Assenagon Asset Management S.A. holds $1,943,463,989 across 69 Biotechnology names. FATE ranks #61 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
759,564 | $377,298,225 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
8,362,952 | $295,964,871 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
244,927 | $152,721,781 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
454,682 | $111,292,513 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,762,086 | $100,826,560 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
997,643 | $78,085,517 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
124,214 | $66,696,707 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
947,495 | $59,635,335 |
All Filings in FATE
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $393,762 | 145,838 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $228,302 | 190,252 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $145,679 | 148,653 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $183,755 | 145,838 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $237,823 | 212,342 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $239,290 | 302,899 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $614,636 | 372,507 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $8,519,693 | 2,434,198 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $8,445,025 | 2,574,703 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $18,704,551 | 2,548,304 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $609,982 | 163,097 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $807,162 | 380,737 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $475,247 | 99,842 | Shares | Sole | 2023-07-25 | |
| 2022-09-30 | $326,805 | 14,583 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $361,887 | 14,604 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $566,429 | 14,610 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $855,123 | 14,615 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $7,379,589 | 124,508 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $36,222,500 | 417,358 | Shares | Sole | 2021-07-15 | |
| 2020-12-31 | $2,302,620 | 25,323 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $3,321,467 | 83,099 | Shares | Sole | 2020-10-07 | |
| 2020-06-30 | $1,385,369 | 40,378 | Shares | Sole | 2020-07-21 | |
| No filing history on record for this holder in this stock. | ||||||